Lipid and Carbohydrate Modifications of α-Galactosylceramide Differently Influence Mouse and Human Type I Natural Killer T Cell Activation.
Birkholz, Alysia; Nemcovic, Marek; Yu, Esther Dawen; Girardi, Enrico; Wang, Jing; Khurana, Archana; Pauwels, Nora; Farber, Elisa; Chitale, Sampada; Franck, Richard W; Tsuji, Moriya; Howell, Amy; Van Calenbergh, Serge; Kronenberg, Mitchell; Zajonc, Dirk M.
J Biol Chem
; 290(28): 17206-17, 2015 Jul 10.
Artigo em Inglês | MEDLINE | ID: mdl-26018083
Recognition of ß-linked self glycolipids mediated by natural killer T cell antigen receptors.
Modeling T cell receptor recognition of CD1-lipid and MR1-metabolite complexes.
Adaptability of the semi-invariant natural killer T-cell receptor towards structurally diverse CD1d-restricted ligands.
A Novel Glycolipid Antigen for NKT Cells That Preferentially Induces IFN-Î³ Production.
Avidity of CD1d-ligand-receptor ternary complex contributes to T-helper 1 (Th1) polarization and anticancer efficacy.
Novel thioglycoside analogs of α-galactosylceramide stimulate cytotoxicity and preferential Th1 cytokine production by human invariant natural killer T cells.
The molecular basis for recognition of CD1d/α-galactosylceramide by a human non-Vα24 T cell receptor.
Differential recognition of CD1d-alpha-galactosyl ceramide by the V beta 8.2 and V beta 7 semi-invariant NKT T cell receptors.
Synthesis of fluorescent glycosphingolipids and neoglycoconjugates which contain 6-gala oligosaccharides using the transglycosylation reaction of a novel endoglycoceramidase (EGALC).
NKT TCR recognition of CD1d-α-C-galactosylceramide.